Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 82

1.

Periodic catatonia with long-term treatment: a case report.

Chen RA, Huang TL.

BMC Psychiatry. 2017 Sep 29;17(1):337. doi: 10.1186/s12888-017-1497-6.

2.

Rapid and simple analysis of disease-associated biomarkers of Taiwanese patients with schizophrenia using matrix-assisted laser desorption ionization mass spectrometry.

Huang TL, Lo LH, Shiea J, Su H.

Clin Chim Acta. 2017 Oct;473:75-81. doi: 10.1016/j.cca.2017.08.011. Epub 2017 Aug 12.

PMID:
28807542
3.

Patient Satisfaction and Quality of Life in People with Schizophrenia-Spectrum Disorders in a Rural Area.

Furrer M, Jakob NJ, Cattapan-Ludewing K, Seixas A, Huber CG, Schneeberger AR.

Adm Policy Ment Health. 2018 Mar;45(2):245-253. doi: 10.1007/s10488-017-0820-3.

PMID:
28756572
4.

Association between community pharmacy loyalty and persistence and implementation of antipsychotic treatment among individuals with schizophrenia.

Zongo FE, Moisan J, Grégoire JP, Lesage A, Dossa AR, Lauzier S.

Res Social Adm Pharm. 2018 Jan;14(1):53-61. doi: 10.1016/j.sapharm.2016.12.006. Epub 2016 Dec 28.

PMID:
28077240
5.

Predicting Employment in the Mental Health Treatment Study: Do Client Factors Matter?

Metcalfe JD, Drake RE, Bond GR.

Adm Policy Ment Health. 2017 May;44(3):345-353. doi: 10.1007/s10488-016-0774-x.

PMID:
27853950
6.

Extracellular elevation of adrenomedullin, a gene associated with schizophrenia, suppresses heat shock protein 1A/1B mRNA.

Zhao Z, Jinde S, Kakiuchi C, Kasai K.

Neuroreport. 2016 Dec 14;27(18):1312-1316.

PMID:
27776076
7.

Higher blood MLL1 mRNA and BDNF promoter IV on histone H3K4me3 levels in patients with schizophrenia.

Huang TL, Lin CC, Chen RF, Lee CT.

Psychiatry Res. 2016 Sep 30;243:207-9. doi: 10.1016/j.psychres.2016.06.010. Epub 2016 Jun 16.

PMID:
27419650
8.

Relapses and recurrences of catatonia: 30-case analysis and literature review.

Lin CC, Hung YY, Tsai MC, Huang TL.

Compr Psychiatry. 2016 Apr;66:157-65. doi: 10.1016/j.comppsych.2016.01.011. Epub 2016 Jan 23.

PMID:
26995249
9.

Integrated Care Pathways for Schizophrenia: A Scoping Review.

Chen S, Awan S, Rajji T, Abdool P, George TP, Collins A, Kidd SA.

Adm Policy Ment Health. 2016 Sep;43(5):760-767. doi: 10.1007/s10488-015-0696-z. Review.

PMID:
26512011
10.

Somatic Care with a Psychotic Disorder. Lower Somatic Health Care Utilization of Patients with a Psychotic Disorder Compared to Other Patient Groups and to Controls Without a Psychiatric Diagnosis.

Swildens W, Termorshuizen F, de Ridder A, Smeets H, Engelhard IM.

Adm Policy Ment Health. 2016 Sep;43(5):650-662. doi: 10.1007/s10488-015-0679-0.

11.

Shortened leukocyte telomere length in patients with schizophrenia is related to disease status.

Lin PY.

Schizophr Res. 2015 Oct;168(1-2):597-8. doi: 10.1016/j.schres.2015.07.038. Epub 2015 Jul 29. No abstract available.

PMID:
26232870
12.

Mental health court outcomes by offense type at admission.

Ray B, Kubiak SP, Comartin EB, Tillander E.

Adm Policy Ment Health. 2015 May;42(3):323-31. doi: 10.1007/s10488-014-0572-2.

PMID:
24965770
13.

Strategies for mHealth research: lessons from 3 mobile intervention studies.

Ben-Zeev D, Schueller SM, Begale M, Duffecy J, Kane JM, Mohr DC.

Adm Policy Ment Health. 2015 Mar;42(2):157-67. doi: 10.1007/s10488-014-0556-2.

14.

Maslow and mental health recovery: a comparative study of homeless programs for adults with serious mental illness.

Henwood BF, Derejko KS, Couture J, Padgett DK.

Adm Policy Ment Health. 2015 Mar;42(2):220-8. doi: 10.1007/s10488-014-0542-8.

15.

The association between suicidality and Internet addiction and activities in Taiwanese adolescents.

Lin IH, Ko CH, Chang YP, Liu TL, Wang PW, Lin HC, Huang MF, Yeh YC, Chou WJ, Yen CF.

Compr Psychiatry. 2014 Apr;55(3):504-10. doi: 10.1016/j.comppsych.2013.11.012. Epub 2013 Nov 27.

PMID:
24457034
16.

Measuring perceived rehabilitation needs of people with schizophrenia in mainland China.

Da Li, Tsui MC, Yuan G, Zhang G, Tsang HW.

Adm Policy Ment Health. 2014 Sep;41(5):636-46. doi: 10.1007/s10488-013-0510-8.

PMID:
23873038
17.

Possible role of adrenomedullin and nitric oxide in major depression.

Akpinar A, Yaman GB, Demirdas A, Onal S.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:120-5. doi: 10.1016/j.pnpbp.2013.07.003. Epub 2013 Jul 16.

PMID:
23867466
18.

Disrupted central inhibition after transcranial magnetic stimulation of motor cortex in schizophrenia with long-term antipsychotic treatment.

Ahlgrén-Rimpiläinen A, Lauerma H, Kähkönen S, Rimpiläinen I.

ISRN Psychiatry. 2013 Mar 14;2013:876171. doi: 10.1155/2013/876171. Print 2013.

19.

Examining the relationship between adjunctive psychotherapy use and antipsychotic persistence and hospitalization.

Wang CC, Maciejewski ML, Rao JK, Sheitman BB, Sleath BL, Farley JF.

Adm Policy Ment Health. 2014 Sep;41(5):598-607. doi: 10.1007/s10488-013-0503-7.

PMID:
23733044
20.

Individual and contextual-level factors associated with continuity of care for adults with schizophrenia.

Fontanella CA, Guada J, Phillips G, Ranbom L, Fortney JC.

Adm Policy Ment Health. 2014 Sep;41(5):572-87. doi: 10.1007/s10488-013-0500-x.

Supplemental Content

Loading ...
Support Center